Learn More
Medchemexpress LLC KGA-2727 | 666842-36-0 | MFCD32701917 | 98.8% | 536.62 | C26H40N4O8 | 25MG

Supplier: Medchemexpress LLC HY12379725MG
KGA-2727 is a selective, high-affinity, orally active sodium-glucose cotransporter 1 (SGLT1) inhibitor used in preclinical research. It competitively inhibits human and rat SGLT1 (Ki 97.4 nM and 43.5 nM, respectively), shows substantial selectivity over SGLT2, and has demonstrated glucose-lowering efficacy in animal diabetes models.
- Selective SGLT1 inhibition with competitive mechanism.
- High affinity for human and rat SGLT1 (Ki ~97.4 nM and 43.5 nM).
- Demonstrated glucose-lowering activity in preclinical diabetic models.
- High reported purity suitable for research use.
- Good solubility in DMSO and ethanol; moderate solubility in water with warming.
- Solid form with defined storage recommendations for stability.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.